Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. DIO Ratio 2011-2026 | ALXN

Annual DIO Ratio Alexion Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
512	581	461	370	531	454	370	211	474	319

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
581	211	428

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Happiness Biotech Group Limited HAPP	1.91 K	-	1.35 %	$ 17.8 M	China
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Esperion Therapeutics ESPR	2.46 K	$ 3.13	-	$ 651 M	USA
	Eton Pharmaceuticals ETON	150	$ 32.59	-6.89 %	$ 877 M	USA
	Affimed N.V. AFMD	69.8	-	-34.95 %	$ 21.5 M	Germany
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Grifols, S.A. GRFS	0.000171	$ 7.98	-1.6 %	$ 5.42 B	Spain
	Autolus Therapeutics plc AUTL	70.7	$ 1.7	3.03 %	$ 452 M	Britain
	Heron Therapeutics HRTX	644	$ 0.86	-1.42 %	$ 143 M	USA
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Anika Therapeutics ANIK	159	$ 14.88	-0.93 %	$ 213 M	USA
	Incyte Corporation INCY	78.4	$ 97.16	-0.26 %	$ 19 B	USA
	Ionis Pharmaceuticals IONS	259	$ 75.56	-0.29 %	$ 12.1 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Coherus BioSciences CHRS	97.5	$ 1.61	2.55 %	$ 189 M	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA